
Sign up to save your podcasts
Or


Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.
By Neuro-Oncology4.8
1212 ratings
Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.

30,687 Listeners

43,741 Listeners

7,707 Listeners

10,749 Listeners

318 Listeners

291 Listeners

3,349 Listeners

112,946 Listeners

56,549 Listeners

10,293 Listeners

9,202 Listeners

5,477 Listeners

16,095 Listeners

18,033 Listeners

10,254 Listeners